Document is current

Article History

Received: 13 September 2023

Accepted: 12 January 2024

First Online: 29 January 2024

Declarations

:

: Not applicable.

: Not applicable.

: GD reports speaker honoraria from Chiesi Ltd and Vertex Pharmaceuticals outside the submitted work.PR reports consultancy fees from Vyaire Medical and Sanofi outside the submitted work.EJH reports honoraria and travel support from Kyowa Kirin; Abbvie; Ever; Bial, The Neurology Academy and CME Institute outside the submitted work.JKQ has received grants from MRC, HDR UK, GSK, BI, asthma + lung UK, and AZ and personal fees for advisory board participation, consultancy or speaking fees from GlaxoSmithKline, Evidera, Chiesi, AstraZeneca, Insmed.MKC was a member of the CONSORT-ROUTINE group. The Health Services Research Unit, where MKC works, receives core funding from the Scottish Government Health Directorates.SBL reports no conflicts of interest.MRSy reports speaker fees at clinical trial statistics training meeting for clinicians (no discussion of particular drugs) from Lilly Oncology; Speaker fees at clinical trial statistics training meeting for clinicians (no discussion of particular drugs) from Janssen; and Educational video on clinical trial statistics (no discussion of particular drugs) from Eisai.MClout reports no conflicts of interest.MC reports no conflicts of interest.JThorn reports no conflicts of interest.MR reports no conflicts of interest.JH reports no conflicts of interest.TJD reports no conflicts of interest.AJF reports no conflicts of interest.None of the other authors reported any conflicts of interest.